Diabetes Diabetics should be aware that Saxenda will likely lower their blood sugars, and adjustments in diabetes medications may be necessary
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (dis CoVeRy): a phase 3, randomised, controlled, open-label trial
The instructional content covered storage, temperature handling, and injection guidance, and the supply set was complete for a first-time injection
The landscape of weight loss solutions has evolved significantly, now encompassing advanced medical therapies that can offer a pathway to healthier living
Safety data from STEP UP demonstrated the tolerable profile of semaglutide 7.2 mg, with most signals mild-to-moderate gastrointestinal events, consistent with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class